Free Trial

Teladoc Health Target of Unusually High Options Trading (NYSE:TDOC)

Teladoc Health logo with Medical background

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) was the recipient of some unusual options trading on Thursday. Stock investors acquired 56,595 call options on the stock. This represents an increase of 307% compared to the average daily volume of 13,903 call options.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on TDOC shares. Barclays upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. Oppenheimer cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research note on Friday, January 24th. The Goldman Sachs Group assumed coverage on Teladoc Health in a research report on Friday, November 15th. They set a "buy" rating and a $14.00 target price for the company. Royal Bank of Canada raised their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, TD Cowen decreased their target price on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, October 31st. Fourteen research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $11.97.

View Our Latest Stock Report on Teladoc Health

Teladoc Health Stock Up 7.0 %

TDOC traded up $0.91 during trading on Monday, hitting $13.86. The stock had a trading volume of 17,055,947 shares, compared to its average volume of 5,547,605. The stock has a 50 day simple moving average of $10.05 and a two-hundred day simple moving average of $9.14. The company has a market capitalization of $2.39 billion, a PE ratio of -2.40 and a beta of 1.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $21.74.

Insider Activity

In other news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares of the company's stock, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.95% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Versant Capital Management Inc boosted its holdings in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after acquiring an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC acquired a new stake in Teladoc Health in the 4th quarter worth approximately $29,000. Lindbrook Capital LLC grew its position in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after purchasing an additional 1,612 shares during the last quarter. Blue Trust Inc. increased its stake in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock valued at $40,000 after purchasing an additional 1,854 shares in the last quarter. Finally, Signaturefd LLC raised its holdings in shares of Teladoc Health by 162.7% in the third quarter. Signaturefd LLC now owns 7,535 shares of the health services provider's stock worth $69,000 after buying an additional 4,667 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Stories

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines